Ian Gilham
Chair of the Board of Trustees at LifeArc | United Kingdom
Ian Gilham’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
VP Pharmacogenetics at GlaxoSmithKline in September 1999 - September 2026
Director Predictive Medicine at GlaxoSmithKline in September 1999 - September 2026
Non-Executive Chair at genedrive plc in May 2015 - Present
Non Executive Chair at RevoNA Bio in February 2023 - Present
Non Executive Director at Novacyt Group in November 2024 - Present
Non Executive Chair at Pelago Bioscience AB in November 2023 - Present
Chair of the Board of Trustees at LifeArc in October 2021 - Present
NonExecutive Chair at Cytox Limited in January 2020 - January 2024
Non Executive Chair at Aptamer Group in December 2021 - August 2023
Non-Executive Chairman at Horizon Discovery in July 2013 - January 2021
Non-Executive Chairman at BioSurfit in March 2013 - March 2020
Non Executive Chairman at Elucigene Diagnostics in June 2017 - April 2019
Chairman at Multiplicom NV in June 2013 - January 2017
CEO at Axis-Shield in January 2008 - December 2011
COO at Axis-Shield in January 2001 - December 2007
Various at Abbott Labs in September 1990 - September 1998
Scientist at Amersham in September 1988 - September 1990
Scientist at Boots-Celltech in September 1984 - September 1988
University of Bath, PhD, September 1981 to September 1984
Bangor University, BSc, September 1978 to September 1981
Wolverhampton Grammar School, September 1971 to September 1978
LifeArc® is a not-for-profit medical research organisation with one clear purpose – transforming the lives of people living with rare diseases and drug-resistant infections. We aim to deliver this by conducting and funding pioneering research, and working with partners to accelerate the translation of scientific breakthroughs into new tests and treatments. Our vision is a world where people living with rare diseases and drug-resistant infections can access effective, life-changing treatments faster. We have been doing this for more than 25 years and our work has resulted in a diagnostic for antibiotic resistance and four licensed medicines. This includes Keytruda®(cancer), Actemra® (rheumatoid arthritis), Tysabri® (multiple sclerosis) and Entyvio® (Crohn’s disease) and a test for antimicrobial resistance. Find out more about our work at www.lifearc.org or follow us on LinkedIn, X (@lifearc1) or Bluesky (@lifearc.bsky.social)
Discover more about LifeArc
Director of Strategy & Operations at LifeArc
Director of Strategy & Operations at LifeArc
(March 2024 – Present)
New Product Planning | Alliance Manager | Life Sciences Advisor | Rare Diseases | Mentor
Director, Independent Consultant at BioMetis Consultancy
(October 2023 – Present)
Senior Analyst, Opportunity Assessment Group at LifeArc | University of Oxford Alumni
Senior Analyst Ventures at LifeArc
(February 2024 – Present)
Senior HR Business Partner at King’s College London
Senior Human Resources Business Partner at LifeArc
(March 2026 – Present)
Chief Technology Officer @ LifeArc making life science life changing | Advisor, Investor
Director, investor and adviser at TRCUK Limited
(November 2008 – Present)
Head of Partnerships, Platforms
Head of Partnerships, Platforms at LifeArc
(April 2025 – Present)
What is Ian Gilham email address?
Email Ian Gilham at [email protected] and [email protected]. This email is the most updated Ian Gilham's email found in 2026.
How to contact Ian Gilham?
To contact Ian Gilham send an email to [email protected] or [email protected]. (updated on April 24, 2026)
What company does Ian Gilham work for?
Ian Gilham works for LifeArc.
What is Ian Gilham's role at LifeArc?
Ian Gilham is Chair of the Board of Trustees
What industry does Ian Gilham work in?
Ian Gilham works in the Biotechnology industry.
